Present State of New Chiral Drug Development and Review in Japan
- 1 January 2008
- journal article
- Published by Pharmaceutical Society of Japan in Journal of Health Science
- Vol. 54 (1) , 23-29
Abstract
The current situation of chiral drug development in Japan was investigated. The trend in the Japanese pharma- ceutical development is increasingly moving towards the development of single isomers rather than racemates. The development of single-enantiomer drugs was made possible by the current technologies of asymmetric synthesis and chiral separation, and encouraged by the guidelines on the development of chiral drugs worldwide. Japan has not issued specific guidelines on the development of chiral drugs, however, the chiral drug development approached in Japan were essentially consistent with the approaches recommended by the U.S.A. and EU guidelines.Keywords
This publication has 4 references indexed in Scilit:
- CHIRAL BUSINESSChemical & Engineering News, 2003
- COUNTING ON CHIRAL DRUGS1998
- Development of chiral drugs in Japan: An update on regulatory and industrial opinionChirality, 1995
- Regulatory aspects of the development of chiral drugs in Japan: A status reportChirality, 1991